Hypoglycaemia unawareness and the brain

Diabetologia

Volumn 45, Issue 7, 2002, Pages 949-958

  Smith, D ^a   Amiel, S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Brain glucose uptake; Catecholamines; Cognitive function; Counterregulation; Diabetes mellitus; Hypoglycaemia; Positron emission tomography

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER;

ARTICLE; BIOSENSOR; BRAIN; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM; COGNITIVE DEFECT; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE BRAIN LEVEL; GLUCOSE TRANSPORT SYSTEM; HUMAN; HYPOGLYCEMIA; PRIORITY JOURNAL; AGING; AWARENESS; BLOOD; HOMEOSTASIS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

AGING; AWARENESS; BLOOD GLUCOSE; BRAIN; CEREBRAL CORTEX; DIABETES MELLITUS; HOMEOSTASIS; HUMAN; HYPOGLYCEMIA; SUPPORT, NON-U.S. GOV'T; HUMANS;

EID: 0036020277     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-002-0877-7     Document Type: Article

References (109)

1. 19410 Insulin hypoglycaemia. Changes in nervous manifestations
2. Hypothalamus and blood glucose regulation
3. The use of tolbutamide-induced hypoglycemia to examine the intraislet role of insulin in mediating glucagon release in normal humans
4. Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes
5. Risk factors of severe hypoglycaemia in adult patients with Type I diabetes - A prospective population based study
6. Intensified insulin therapy and the risk of severe hypoglycaemia
7. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impiared glucagon secretion
8. Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes mellitus
9. Autonomic mediation of glucagon secretion during hypoglycemia: Implications for impaired alpha-cell responses in type 1 diabetes
10. Stimulation of glucose production through hormone secretion and other mechanisms during insulin-induced hypoglycemia
11. Effect of hypoglycemia on amino acid and protein metabolism in healthy humans
12. Contribution of cortisol to glucose counterregulation in humans
13. Demonstration of a role for growth hormone in glucose
14. Contribution of adrenergic mechanisms to glucose counterregulation in humans
15. Effects of physiological hyperinsulinemia on systemic, renal, and hepatic substrate metabolism
16. Uptake and release of glucose by the human kidney: Postabsoprtive rates and responses to epinephrine
17. Renal lactate metabolism and gluconeogenesis during insulin induced hypoglycaemia
18. Renal glucose production compensates for the liver during the anhepatic phase of liver transplantation
19. Intensive blood glucose control with sulphonylureas or insulin compared with conventional therapy and risk of complications in patients with Type 2 diabetes mellitus, UKPDS 33
20. Decreased severe hypoglycemia frequency during intraperitoneal insulin infusion using programmable implantable pumps
21. Long-term therapy of IDDM with an implantable insulin pump
22. Post-transplantation hypoglycaemia in type 1 diabetic pancreas allograft recipients
23. Incidence of severe hypoglycaemia requiring emergency treatment in Type 1 and Type 2 diabetes: A population based study of health service resource use
24. Unawareness of hypoglycaemia and ijnadequate hypoglycaemic counterregulation: No causla relationship with diabetic autonomic neuropathy
25. Identification of Type I diabetic patients at increased risk for hypoglycemia during intensive therapy
26. Glucose sensing by the hepatoportal sensor is GLUT2-dependent: In vivo analysis in GLUT2-null mice
27. Novel glucosensor for hypoglycemic detection localized to the portal vein
28. Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia
29. Hepatic vagotomy does not alter plasma insulin response to a low dose injection of glucose
30. Effect of hepatic denervation on the counterregulatory response to insulin-induced hypoglycemia in the dog
31. Hypoglycemic detection in the protal vein is mediated by capsaicin-sensitive afferents
32. A portal-arterial glucose concentration gradient as a signal for an insulin-dependent net glucose uptake in perfused rat liver
33. Food intake inhibition elicited by intraportal glucose and adrenaline in dogs on a 22 hour-fasting/2 hour feeding schedule
34. Regulation of glucose homeostasis in humans with denervated livers
35. Oral glucose augments the counterregulatory response during insulin-induced hypoglycemia in humans
36. Role of the brain in counterregulation of insulin induced hypoglycaemia in dogs
37. Counterregulation during hypoglycaemia is directed by widespread brain organs
38. Putative hypothalamic glucoreceptors play no essential role in the response to moderate hypoglycemia
39. Response to deep hypoglycemia does not involve glucoreceptors in carotid perfused tissue
40. Subgroups of hindbrain catecholamine neurons are selectively activated by 2-deoxy-D-glucose induced metabolic challenge
41. Convergence of pre- and postsynaptic influences on glucosensing neurons in the ventromedial hypothalamic nucleus
42. Glucose-regulated dopamine release from substantia nigra neurons
43. Glucose modulates rat substantia nigra GABA release in vivo via ATP-sensitive potassium channels
44. Central glucoprivation evoked by administration of 2-deoxy-D-glucose induces expression of the c-fos gene in a subpopulation of neuropeptide Y neurons in the rat hypothalamus
45. Glucoprivic induction of Fos immunoreactivity in hypothalamic dopaminergic neurons
46. Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut
47. Specific inhibition of GLUT2 in arcuate nucleus by antisense oligonucleotides suppresses nervous control of insulin secretion
48. Distribution and phenotype of neurons containing the ATP-sensitive K+ channel in rat brain
49. Sulfonylureas enhance GABAA synaptic potentials in rat midbrain dopamine neurones
50. Counterregulatory responses to hypoglycaemia in patients with glucokinase gene mutations
51. Is glucokinase the hypothalamic glucose sensor?
52. Ketone infusion lowers hormonal responses to hypoglycaemia: Evidence for acute cerebral utilization of a non-glucose fuel
53. Protection by lactate of cerebral function during hypoglycaemia
54. Reduced counterregulation during hypoglycemia with raised circulating non-glucose lipid substrates: Evidence for regional differences in metabolic capacity in the human brain?
55. Effect of hyperketonemia and hyperlacticacidemia on symptoms, cognitive dysfunction and counterregulatory hormone responses during hypoglcyemia in normal humans
56. Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis
57. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics
58. Hypoglycaemic conunterregulation at "normal" blood glucose concentrations in patients with well-controlled Type 2 diabetes
59. Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia
60. Unawareness of hypoglycaemia in insulin treated diabetic patients: Prevalence and relationship to autonomic neuropathy
61. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus
62. Altered recognition of hypoglycaemic symptoms in Type 1 diabetes during intensified control with continuous subcutaneous insulin infusion
63. Defective glucose counterregulation after strict control of insulin-dependent diabetes mellitus
64. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release
65. Lack of preservation of higher brain function during hypoglycaemia in patients with intensively treated insulin dependent diabetes mellitus
66. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycaemia in non-diabetic humans
67. Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans
68. Prolonged but partial impairment of the hypoglycaemic physiological response following short-term hypoglycaemia in normal subjects
69. Brief twice-weekly episodes of hypoglycemia reduce detection of clinical hypoglycemia in type 1 diabetes mellitus
70. Impact of nocturnal hypoglycemia on hypoglycemic cognitive dysfunction in type 1 diabetes
71. Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM
72. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes
73. Lack of hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients
74. Effect of hypoglycemia on beta-adrenergic sensitivity in normal and type 1 diabetic subjects
75. Reversal of hypoglycemia unawareness, but not defective glucose ounterregulation, in IDDM
76. Effects of autonomic neuropathy on counterregulation and awareness of hypoglycemia in type 1 diabetic patients
77. Is autonomic neuropathy a risk factor for severe hypoglycaemia? The EURODIAB IDDM Complications study
78. Lack of hypoglycemic symptoms and decreased beta-adrenergic sensitivity in insulin-dependent diabetic patients
79. Long-term intensive therapy of IDDM patients with clinically overt autonomic neuropathy: Effects on hypoglycemia awareness and counterregulation
80. Cognitive function and mood after profound nocturnal hypoglycaemia in prepubertal children with conventional insulin treatment for diabetes
81. Limitations of conventional methods of self-monitoring of blood glucose: Lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes
82. Hexose uptake in primary cultures of bovine brain microvessel endothelial cells. I. Basic characteristics and effects of D-glucose and insulin
83. Chronic insulin hypoglycemia induces GLUT-3 protein in rat brain neurons
84. Adaptation in brain glucose uptake following recurrent hypoglycemia
85. Brain glucose uptake and unawareness of hypoglycemia in patients with insulin dependent diabetes mellitus
86. Regional cerebral glucose transport in insulin-dependent diabetic patients studied using [11C]3-O-methyl-D-glucose and positron emission tomography
87. Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia
88. Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans
89. Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms and cerebral dysfunction
90. Impact of recent antecedent hypoglycemia on hypoglycemic cognitive dysfunction in non diabetic humans
91. The effect of acute hypoglycemia on brain function and activation: A functional magnetic resonance imaging study
92. Hormonal and metabolic effects of neuroglucopenia
93. Ventromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia
94. Local ventromedial hypothalamus glucopenia triggers counterregulatory hormone release
95. Local ventromedial hypothalamus glucose perfusion blocks counterregulation during systemic hypoglycemia in awake rats
96. Chronic hypoglycemia and diabetes impair counterregulation induced by localized 2-deoxyglucose perfusion of the ventromedial hypothalamus in rats
97. Presumed apoptosis and reduced arcuate nucleus neuropeptide Y and pro-opiomelanocortin mRNA in non-coma hypoglycemia
98. Prevention of an increase in plasma cortisol during hypoglycemia preserves subsequent counterregulatory responses
99. 18F-fluorodeoxyglucose uptake at hypoglycemia in Type 1 diabetic men associated with hypoglycemia unawareness and counterregulatory failure
100. Impaired counterregulation of glucose in a patient with hypothalamic sarcoidosis
101. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas
102. Utilization of antidiabetic drugs in Hong Kong: Relation to the common occurrence of antidiabetic drug induced hypoglycemia amongst acute medical admissions and the relative prevalence of NIDDM
103. Higher incidence of severe hypoglycaemia leading to hospital admission in type 2 diabetic patients treated with long acting versus short acting sulphonylureas
104. Perceived symptoms of hypoglycaemia in elderly type 2 diabetic patients treated with insulin
105. Altered hierarchy of protective responses against severe hypoglycemia in normal aging in healthy men
106. Exaggerated epinephrine responses to hypoglycemia in normal and insulin-dependent diabetic children
107. Symptoms of hypoglcyaemia in children
108. The effect of hypoglycemic seizures on cognitive function in children with diabetes: A 7-year prospective study
109. Cumulative cognitive impairment following recurrent severe hypoglycaemia in adult patients with insulin-treated diabetes mellitus